Dean G. Tang

Developing folate-conjugated miR-34a therapeutic for prostate cancer treatment: Challenges and promises

A. Kasinski, Xiaozhuo Liu, Wen (Jess) Li, 2023, bioRxiv.

Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises

A. Kasinski, J. Spernyak, Steven G. Turowski, 2024, International journal of molecular sciences.

Treatment-induced stemness and lineage plasticity in driving prostate cancer therapy resistance

Xiaozhuo Liu, Anmbreen Jamroze, Dean G. Tang, 2024, Cancer Heterogeneity and Plasticity.

Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells

Song Liu, J. Wrana, Jiaoti Huang, 2023, bioRxiv.

Developing a Novel Two‐Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer

K. Lin, Y. Zhong, Jianjun Shen, 2016, Stem Cells Translational Medicine.

Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy.

C. Zou, Qinju He, Ruizhe Zhao, 2024, Cancer letters.

Developing a Novel Two‐Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer

K. Lin, Yue Lu, Y. Zhong, 2016, Stem cells translational medicine.